BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3743448)

  • 1. [Optimization of levothyroxine treatment. Dosage dependence on the existing parenchymal mass, age, body weight and fasting intake].
    Wenzel KW
    Dtsch Med Wochenschr; 1986 Sep; 111(36):1356-62. PubMed ID: 3743448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
    Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
    Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of the optimal L-thyroxine dosage for treating nontoxic goiter].
    Biersack HJ; Albrecht W; Oehr P; Rasche A; Winkler C
    Dtsch Med Wochenschr; 1983 Aug; 108(34):1269-73. PubMed ID: 6411440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of goiter treatment with L-thyroxine in patients over 40].
    Wollmann B; Meller J; Hüfner M; Becker W
    Nuklearmedizin; 1998 Jan; 37(1):41-4. PubMed ID: 9467169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levothyroxine dose following thyroidectomy is affected by more than just body weight.
    Baehr KM; Lyden E; Treude K; Erickson J; Goldner W
    Laryngoscope; 2012 Apr; 122(4):834-8. PubMed ID: 22374624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.
    Fast S; Bonnema SJ; Hegedüs L
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):653-8. PubMed ID: 18363890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroxine vs iodine and thyroxine. Comparison of the TSH suppression test].
    Kahaly G; Mihaljevic V; Beyer J; Krause U
    Schweiz Med Wochenschr; 1989 Jan; 119(2):59-64. PubMed ID: 2492674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease.
    Di Donna V; Santoro MG; de Waure C; Ricciato MP; Paragliola RM; Pontecorvi A; Corsello SM
    Thyroid; 2014 Dec; 24(12):1759-64. PubMed ID: 25268754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
    La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE
    Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination therapy of endemic goiter with two different thyroxine/iodine combinations].
    Klemenz B; Förster G; Wieler H; Kahaly G; Kaiser KP; Hansen C; Willkomm P; Ruhlmann J
    Nuklearmedizin; 1998 May; 37(3):101-6. PubMed ID: 9604230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism.
    Davis FB; LaMantia RS; Spaulding SW; Wehmann RE; Davis PJ
    Arch Intern Med; 1984 Sep; 144(9):1752-4. PubMed ID: 6433829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.
    Glymph K; Gosmanov AR
    Endocr Pract; 2016 Jan; 22(1):22-9. PubMed ID: 26437220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal daily levothyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes.
    Kabadi UM
    Arch Intern Med; 1989 Oct; 149(10):2209-12. PubMed ID: 2508585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levothyroxine Therapy in Thyrodectomized Patients.
    Miccoli P; Materazzi G; Rossi L
    Front Endocrinol (Lausanne); 2020; 11():626268. PubMed ID: 33584551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial.
    Bolk N; Visser TJ; Nijman J; Jongste IJ; Tijssen JG; Berghout A
    Arch Intern Med; 2010 Dec; 170(22):1996-2003. PubMed ID: 21149757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
    Wadwekar D; Kabadi UM
    Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Posologic equivalents of oral L-thyroxine in thyroid insufficiency (120 cases)].
    Ann Med Interne (Paris); 1983; 134(7):636-42. PubMed ID: 6666901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.